TG Therapeutics | TGTX - Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.55B 757M 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Amgen USD 1.79B 128M 2025-12
Ardelyx USD 10.85M 6.87M 2025-12
Bayer EUR 4.5B 194M 2025-12
Biogen USD 810.1M 205.1M 2025-09
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Curis USD 10.27M 610K 2024-06
Gilead Sciences USD 1.62B 50M 2025-12
Infinity Pharmaceuticals USD 352K 89K 2023-06
J&J USD 7.97B 689M 2025-12
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
Novartis USD 3.54B 3M 2025-12
Novavax USD 22.1M 608K 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
TG Therapeutics USD 38.14M 10.05M 2025-12
Verastem USD 0 0 2021-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12